Current and Future of Alzheimer's therapy with the best approach.

CONCLUSION: In conclusion, the new approaches seem to aim at examining the prospective neuroprotective activity of diseasemodifying drugs in the pre-symptomatic phases of AD, using biomarkers that detect progression of the disease before the growth of overt dementia. PMID: 32351189 [PubMed - as supplied by publisher]
Source: CNS and Neurological Disorders Drug Targets - Category: Drugs & Pharmacology Authors: Tags: CNS Neurol Disord Drug Targets Source Type: research